分层医疗与阶梯医疗对抑郁的疗效比较:整群随机临床试验
该多中心整群随机临床试验于2018年7月至2019年2月从英国国家卫生服务体系招募951例常见精神障碍成人患者,比较分层医疗与阶梯医疗对抑郁症状的疗效与成本效益。分层医疗组抑郁症状治疗后可靠且临床显著改善比例为52.3%,显著高于阶梯医疗组的45.1%(OR 1.40,95%CI 1.04-1.87,P=0.03),但人均额外成本增加104.5英镑(95%CI 67.5-141.6),作者认为分层医疗有效且具成本效益。
要点
- 分层医疗组抑郁症状可靠且临床显著改善比例52.3%,高于阶梯医疗组45.1%(OR 1.40,95%CI 1.04-1.87,P=0.03)。
- 分层医疗组人均额外成本104.5英镑(95%CI 67.5-141.6),因更多患者接受高强度治疗(56.9% vs 29.1%,P<0.001)。
- 额外成本带来可靠且临床显著改善概率约增加7%,作者认为分层医疗有效且具成本效益。
核心结论
- 在常见精神障碍成人中,分层医疗对抑郁症状的疗效和成本效益优于阶梯医疗。
- 分层医疗可以适度额外成本改善抑郁治疗结局。
研究设计与样本
- 多中心整群随机临床试验,2018年7月5日至2019年2月1日从英国国家卫生服务体系招募受试者。
- 30名临床医生随机分配至分层医疗组(n=15)或阶梯医疗组(n=15),共纳入951例患者。
- 阶梯医疗中患者依次接受低强度引导式自助后高强度心理治疗;分层医疗在初始评估时将患者匹配至低强度或高强度治疗。
- 分层医疗组临床医生使用机器学习算法为每例患者生成个性化治疗推荐。
- 主要结局为抑郁症状(9项患者健康问卷)治疗后可靠且临床显著改善,采用意向性治疗原则分析。
主要发现
- 分层医疗组可靠且临床显著改善比例为264/505(52.3%),阶梯医疗组为134/297(45.1%),OR 1.40(95%CI 1.04-1.87),P=0.03。
- 分层医疗组接受高强度治疗比例为332/583(56.9%),阶梯医疗组为107/368(29.1%),χ2=70.51,P<0.001。
- 分层医疗组人均额外成本为104.5英镑(95%CI 67.5-141.6)或139.83美元(95%CI 90.32-189.48),P<0.001。
- 额外成本带来可靠且临床显著改善概率约增加7%。
关键数值与推荐
- 主要结局采用9项患者健康问卷测量抑郁症状,以可靠且临床显著改善为指标。
- 组间比较采用校正基线严重度的逻辑回归。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Depression is a major cause of disability worldwide. Although empirically supported treatments are available, there is scarce evidence on how to effectively personalize psychological treatment selection. OBJECTIVE: To compare the clinical effectiveness and cost-effectiveness of 2 treatment selection strategies: stepped care and stratified care. DESIGN, SETTING, AND PARTICIPANTS: This multisite, cluster randomized clinical trial recruited participants from the English National Health Service from July 5, 2018, to February 1, 2019. Thirty clinicians working across 4 psychological therapy services were randomly assigned to provide stratified (n = 15) or stepped (n = 15) care. In stepped care, patients sequentially access low-intensity guided self-help followed by high-intensity psychotherapy. In stratified care, patients are matched with either low- or high-intensity treatments at initial assessment. Data were analyzed from May 18, 2020, to October 13, 2021, using intention-to-treat principles. INTERVENTIONS: All clinicians used the same interview schedule to conduct initial assessments with patients seeking psychological treatment for common mental disorders, but those in the stratified care group received a personalized treatment recommendation for each patient generated by a machine learning algorithm. Eligible patients received either stratified or stepped care (ie, treatment as usual). MAIN OUTCOMES AND MEASURES: The preregistered outcome was posttreatment reliable and clinically significant improvement (RCSI) of depression symptoms (measured using the 9-item Patient Health Questionnaire). The RCSI outcome was compared between groups using logistic regression adjusted for baseline severity. Cost-effectiveness analyses compared incremental costs and health outcomes of the 2 treatment pathways. RESULTS: A total of 951 patients were included (618 women among 950 with data available [65.1%]; mean [SD] age, 38.27 [14.53] years). The proportion of cases of RCSI was significantly higher in the stratified care arm compared with the stepped care arm (264 of 505 [52.3%] vs 134 of 297 [45.1%]; odds ratio, 1.40 [95% CI, 1.04-1.87]; P = .03). Stratified care was associated with a higher mean additional cost per patient (£104.5 [95% CI, £67.5-£141.6] [$139.83 (95% CI, $90.32-$189.48)]; P < .001) because more patients accessed high-intensity treatments (332 of 583 [56.9%] vs 107 of 368 [29.1%]; χ2 = 70.51; P < .001), but this additional cost resulted in an approximately 7% increase in the probability of RCSI. CONCLUSIONS AND RELEVANCE: In this cluster randomized clinical trial of adults with common mental disorders, stratified care was efficacious and cost-effective for the treatment of depression symptoms compared with stepped care. Stratified care can improve depression treatment outcomes at a modest additional cost. TRIAL REGISTRATION: isrctn.org Identifier: ISRCTN11106183.
引用
- Delgadillo J, Ali S, Fleck K, et al. Stratified Care vs Stepped Care for Depression: A Cluster Randomized Clinical Trial. JAMA Psychiatry. 2022. PMID: 34878526. doi:10.1001/jamapsychiatry.2021.3539
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。